You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 17, May 6, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Pain
 •Substance Abuse/ Alcoholism
 •Quality of Care
 •Patient Safety/ Medical Error
 •Drug Therapy
 •Adverse Effects
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prescription Opioids and Overdose Deaths

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In response to the Editorial by Drs McLellan and Turner,1 the main problem with long-term use of opioids for chronic pain is the inability to ensure that the prescribed medications are actually being taken by the patient. Opioids have a huge street value, which may present patients with an overwhelming temptation to sell or trade their pills. My patients report that hydrocodone with acetaminophen sells on the street for $1 per milligram and that long-acting opioids without additives sell for more and present a greater risk for intravenous use. A single oxycodone 80-mg tablet may have a street value of $130. With dosing 3 times a day, this equates to $12 000 every month. While this may not be a starting dose, it is often reached over time. In addition to long-acting opioids, patients with chronic pain may get a second prescription for immediate release opioids to treat . . . [Full Text of this Article]

Michael Merrick, MD
mmerrick@alaska.com
Kenai, Alaska



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities
Aron J. Hall, Joseph E. Logan, Robin L. Toblin, James A. Kaplan, James C. Kraner, Danae Bixler, Alex E. Crosby, and Leonard J. Paulozzi
JAMA. 2008;300(22):2613-2620.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Prescription Opioids and Overdose Deaths
Noni A. Graham, Mark S. Gold, and Bruce A. Goldberger
JAMA. 2009;301(17):1766.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Richard D. Layne, Ronald J. Pellegrino, and Nathan M. Lerfald
JAMA. 2009;301(17):1766-1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Robert Newman
JAMA. 2009;301(17):1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths—Reply
Aron J. Hall and Leonard J. Paulozzi
JAMA. 2009;301(17):1767-1768.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths—Reply
A. Thomas McLellan and Barbara J. Turner
JAMA. 2009;301(17):1768-1769.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.